sk&f 83959 has been researched along with thapsigargin in 1 studies
| Studies (sk&f 83959) | Trials (sk&f 83959) | Recent Studies (post-2010) (sk&f 83959) | Studies (thapsigargin) | Trials (thapsigargin) | Recent Studies (post-2010) (thapsigargin) |
|---|---|---|---|---|---|
| 94 | 0 | 46 | 5,234 | 3 | 918 |
| Protein | Taxonomy | sk&f 83959 (IC50) | thapsigargin (IC50) |
|---|---|---|---|
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Long, L; Ming, Y; Wang, F; Zhang, H; Zhen, X | 1 |
1 other study(ies) available for sk&f 83959 and thapsigargin
| Article | Year |
|---|---|
Modulation of Ca2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Calcium; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hippocampus; Isoenzymes; Neurons; Phosphatidylinositols; Phospholipase C beta; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Second Messenger Systems; Thapsigargin; Type C Phospholipases | 2006 |